Concepedia

Publication | Closed Access

Stability of HER-2/neu Expression Over Time and at Multiple Metastatic Sites

DOI

164

Citations

0

References

1993

Year

G A Niehans, Timothy P. Singleton, D Dykoski, David T. Kiang
JNCI Journal of the National Cancer Institute

Abstract

The fact that p185 immunoreactivity is rarely heterogeneous is encouraging, both for the potential use of HER-2/neu-related proteins as serum tumor markers and for innovative therapies targeted at p185 expression.